Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

ADX71943 and ADX71441, novel positive allosteric modulators of the GABAB receptor with distinct central/peripheral profiles, show efficacy in the monosodium iodoacetate model of chronic osteoarthritis pain in the rat.

Kalinichev M, Donovan-Rodriguez T, Girard F, Haddouk H, Royer-Urios I, Schneider M, Bate ST, Marker C, Pomonis JD, Poli S.

Eur J Pharmacol. 2017 Jan 15;795:43-49. doi: 10.1016/j.ejphar.2016.11.056. Epub 2016 Dec 1.

PMID:
27916555
2.

Preclinical Pharmacological Approaches in Drug Discovery for Chronic Pain.

Whiteside GT, Pomonis JD, Kennedy JD.

Adv Pharmacol. 2016;75:303-23. doi: 10.1016/bs.apha.2015.12.002. Epub 2016 Jan 21. Review.

PMID:
26920017
3.

An industry perspective on the role and utility of animal models of pain in drug discovery.

Whiteside GT, Pomonis JD, Kennedy JD.

Neurosci Lett. 2013 Dec 17;557 Pt A:65-72. doi: 10.1016/j.neulet.2013.08.033. Epub 2013 Aug 27. Review.

PMID:
23994390
4.

The monosodium iodoacetate model of osteoarthritis pain in the rat.

Marker CL, Pomonis JD.

Methods Mol Biol. 2012;851:239-48. doi: 10.1007/978-1-61779-561-9_18.

PMID:
22351096
5.

Complement activation in the peripheral nervous system following the spinal nerve ligation model of neuropathic pain.

Levin ME, Jin JG, Ji RR, Tong J, Pomonis JD, Lavery DJ, Miller SW, Chiang LW.

Pain. 2008 Jul;137(1):182-201. Epub 2007 Dec 21.

PMID:
18160218
6.

Pharmacology of 2-[4-(4-chloro-2-fluorophenoxy)phenyl]-pyrimidine-4-carboxamide: a potent, broad-spectrum state-dependent sodium channel blocker for treating pain states.

Ilyin VI, Pomonis JD, Whiteside GT, Harrison JE, Pearson MS, Mark L, Turchin PI, Gottshall S, Carter RB, Nguyen P, Hogenkamp DJ, Olanrewaju S, Benjamin E, Woodward RM.

J Pharmacol Exp Ther. 2006 Sep;318(3):1083-93. Epub 2006 May 25.

7.

Development and pharmacological characterization of a rat model of osteoarthritis pain.

Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K.

Pain. 2005 Apr;114(3):339-46. Epub 2004 Dec 19.

PMID:
15777859
8.

Intra-amygdalar injection of DAMGO: effects on c-Fos levels in brain sites associated with feeding behavior.

Levine AS, Olszewski PK, Mullett MA, Pomonis JD, Grace MK, Kotz CM, Billington CJ.

Brain Res. 2004 Jul 23;1015(1-2):9-14.

PMID:
15223361
9.

Endothelin and the tumorigenic component of bone cancer pain.

Peters CM, Lindsay TH, Pomonis JD, Luger NM, Ghilardi JR, Sevcik MA, Mantyh PW.

Neuroscience. 2004;126(4):1043-52.

PMID:
15207337
10.

DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-yl]-acetic acid), a novel, systemically available, and peripherally restricted Mu opioid agonist with antihyperalgesic activity: II. In vivo pharmacological characterization in the rat.

Whiteside GT, Harrison JE, Pearson MS, Chen Z, Fundytus ME, Rotshteyn Y, Turchin PI, Pomonis JD, Mark L, Walker K, Broglé KC.

J Pharmacol Exp Ther. 2004 Aug;310(2):793-9. Epub 2004 Mar 30. Erratum in: J Pharmacol Exp Ther. 2005 Mar;312(3):1334. Fundytus, Marian E [added].

11.

Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure.

Egnaczyk GF, Pomonis JD, Schmidt JA, Rogers SD, Peters C, Ghilardi JR, Mantyh PW, Maggio JE.

Proteomics. 2003 May;3(5):689-98.

PMID:
12748948
13.

Endothelin receptor expression in the normal and injured spinal cord: potential involvement in injury-induced ischemia and gliosis.

Peters CM, Rogers SD, Pomonis JD, Egnaczyk GF, Keyser CP, Schmidt JA, Ghilardi JR, Maggio JE, Mantyh PW.

Exp Neurol. 2003 Mar;180(1):1-13. Erratum in: Exp Neurol. 2003 Aug;182(2):518. Egnazyck, Gregory F [corrected to Egnaczyk, Gregory F].

PMID:
12668144
14.

Endothelin B receptors are expressed by astrocytes and regulate astrocyte hypertrophy in the normal and injured CNS.

Rogers SD, Peters CM, Pomonis JD, Hagiwara H, Ghilardi JR, Mantyh PW.

Glia. 2003 Jan 15;41(2):180-90.

PMID:
12509808
15.

Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain.

Luger NM, Sabino MA, Schwei MJ, Mach DB, Pomonis JD, Keyser CP, Rathbun M, Clohisy DR, Honore P, Yaksh TL, Mantyh PW.

Pain. 2002 Oct;99(3):397-406.

PMID:
12406514
16.

Origins of skeletal pain: sensory and sympathetic innervation of the mouse femur.

Mach DB, Rogers SD, Sabino MC, Luger NM, Schwei MJ, Pomonis JD, Keyser CP, Clohisy DR, Adams DJ, O'Leary P, Mantyh PW.

Neuroscience. 2002;113(1):155-66.

PMID:
12123694
17.

Expression and localization of endothelin receptors: implications for the involvement of peripheral glia in nociception.

Pomonis JD, Rogers SD, Peters CM, Ghilardi JR, Mantyh PW.

J Neurosci. 2001 Feb 1;21(3):999-1006.

18.

Sucrose consumption increases naloxone-induced c-Fos immunoreactivity in limbic forebrain.

Pomonis JD, Jewett DC, Kotz CM, Briggs JE, Billington CJ, Levine AS.

Am J Physiol Regul Integr Comp Physiol. 2000 Mar;278(3):R712-9.

19.

Discriminative stimulus effects of morphine: central versus peripheral training.

Cleary JP, O'Hare E, Pomonis JD, Dittel PL, Hofmeister JJ, Fritz MM, Billington CJ, Levine AS.

Brain Res. 1999 Nov 13;847(1):26-31.

PMID:
10564732
20.

Neural site of leptin influence on neuropeptide Y signaling pathways altering feeding and uncoupling protein.

Kotz CM, Briggs JE, Pomonis JD, Grace MK, Levine AS, Billington CJ.

Am J Physiol. 1998 Aug;275(2 Pt 2):R478-84.

PMID:
9688683
21.

Intrahypothalamic discriminative stimulus effects of neuropeptide Y.

O'Hare E, Cleary J, Weldon DT, Pomonis JD, Billington CJ, Levine AS.

Pharmacol Biochem Behav. 1998 Feb;59(2):375-8.

PMID:
9476984
23.

Orphanin FQ, agonist of orphan opioid receptor ORL1, stimulates feeding in rats.

Pomonis JD, Billington CJ, Levine AS.

Neuroreport. 1996 Dec 20;8(1):369-71.

PMID:
9051812

Supplemental Content

Loading ...
Support Center